Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA accepts Alpharma's Embeda capsule NDA filing

Sep. 3, 2008

GPR88 identified as a potential target in psychiatric disorders

Sep. 3, 2008

Novel alpha7 neuronal nicotinic receptor agonists synthesized at Abbott

Sep. 3, 2008

Silymarin improves learning and memory in experimental rats

Sep. 2, 2008

Neuroprotective mechanism of Gammagard Liquid shown in vitro

Sep. 2, 2008

Recent sanofi-aventis patent discloses new analgesic agents

Sep. 1, 2008

S-Methylisothiourea reduces cerebral ischemia damage in vivo

Sep. 1, 2008

Immunoglobulin intravenous appears safe over 48 weeks in CIDP patients

Sep. 1, 2008

Allon presents phase II MCI-CABG results

Aug. 29, 2008

Valeant and GlaxoSmithKline enter worldwide collaboration for retigabine

Aug. 29, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...